Available option
5mg
Lyophilised powder
- Strength
- 5mg
- Format
- Lyophilised powder
Bear Biotech catalogue
AOD-9604
Modified human-growth-hormone fragment research material
- Adipose models
- Metabolic research
- HGH-fragment identity
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Research overview
What is AOD-9604?
AOD-9604 is a modified C-terminal fragment of human growth hormone studied mainly in adipocyte and metabolic research. Interest centres on whether selected GH-fragment biology can be separated from the broader growth-promoting actions of full-length growth hormone. Human efficacy evidence remains limited.
Mainly preclinical; limited published human efficacy evidence
Research focus
Key research areas
AOD-9604 research: a modified growth-hormone fragment
AOD-9604 is an engineered peptide derived from the C-terminal region of human growth hormone. Exact sequence and preparation must be established before interpreting experimental metabolic endpoints. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- Adipose models
- Metabolic research
- HGH-fragment identity
Representative primary research
Representative research
A preclinical study examined the named synthetic human-growth-hormone-derived analogue in obese Zucker rats.
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone ↗ Original animal research; it does not establish a human outcome.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- AOD-9604
- Research category
- Modified human-growth-hormone fragment research material
- Evidence position
- Mainly preclinical; limited published human efficacy evidence
- Recorded formats
- Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
Why is growth-hormone-fragment identity important in AOD-9604 research?
AOD-9604 research focuses on a growth-hormone-fragment identity in adipose and metabolic models. Sequence confirmation is essential to connect a material with that literature.
What can adipose and metabolic models reveal about AOD-9604?
Adipose models examine cellular or animal metabolic endpoints rather than proving a human body-composition outcome. Protocol and material identity determine relevance.
Why does limited human efficacy evidence constrain AOD-9604 conclusions?
AOD-9604 evidence is mainly preclinical, with limited published human efficacy evidence. It should not be presented as an established metabolic treatment.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.